This inventor holds 18 USPTO granted patents and 15 published patent applications and 11 EPO patents, primarily in Nucleic Acid Detection. Top assignee: Qiagen Gmbh. Active years: 2012-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Duesseldorf, DE (2014)
- Düsseldorf, DE (2012 - 2016)
- Lieden, DE (2016)
- Hilden, DE (2012 - 2023)
Company Filing History:
Years Active: 2012-2026
Areas of Expertise:
Sure! Here is the article about inventor Ralf Peist based on the given data:
Title: Innovator Spotlight: Ralf Peist - Leading the Way in Nucleic Acid Assessment
Introduction:
In the realm of nucleic acid assessment innovations, one name stands out - Ralf Peist. Hailing from Hilden, DE, this prolific inventor has made significant contributions with his groundbreaking patents. With an impressive portfolio of 16 patents, Ralf Peist continues to push the boundaries of nucleic acid research.
Latest Patents:
Ralf Peist's latest patents showcase his expertise in the field. The "Kit for determining nucleic acid degradation" revolutionizes the assessment of nucleic acid degradation, offering a novel way to determine integrity. Additionally, the "Cation chelator hot start" patent focuses on regulating enzymatic activity in nucleic acid modifying reactions, enhancing specificity in PCR experiments.
Career Highlights:
Currently affiliated with Qiagen GmbH, Ralf Peist has found the perfect platform to nurture his innovative spirit. His journey is marked by a relentless pursuit of excellence and a commitment to advancing nucleic acid research. Through his patents, he has solidified his position as a trailblazer in the field.
Collaborations:
In the collaborative landscape of innovation, Ralf Peist has worked alongside notable colleagues such as Dirk Löffert and Miroslav Vranes. This collaborative effort has resulted in synergistic developments and enriched the scientific community with valuable insights and inventions.
Conclusion:
Ralf Peist's impact on nucleic acid assessment is immeasurable, with his patents shaping the future of the field. His dedication, coupled with a vision for transformative solutions, continues to inspire both his peers and the next generation of inventors. As he paves the way for new possibilities in nucleic acid research, Ralf Peist remains a driving force of innovation.
Should you need more information or assistance on inventors, patents, or innovations, feel free to reach out!
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile